Ligand Pharmaceuticals, Inc. (LGND)
237.73
+0.73
(+0.31%)
USD |
NASDAQ |
Jun 08, 16:00
237.73
0.00 (0.00%)
After-Hours: 16:39
Ligand Pharmaceuticals Market Cap : 4.761B for June 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Organon & Co. | 3.516B |
| Johnson & Johnson | 558.83B |
| Merck & Co., Inc. | 295.13B |
| ANI Pharmaceuticals, Inc. | 1.834B |
| Corcept Therapeutics, Inc. | 7.871B |
Market Cap Related Metrics
| PE Ratio | 32.23 |
| PS Ratio | 17.66 |
| Price to Book Value | 4.774 |
| Price to Free Cash Flow | 42.51 |
| Price | 237.73 |
| Earnings Yield | 3.10% |
| Operating PE Ratio | 47.90 |
| Normalized PE Ratio | 37.77 |